Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nursing home drug safety study aims to cut risky prescribing

NCT ID NCT07407387

Not yet recruiting Knowledge-focused Sponsor: Lugano Istituti Sociali Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a team of clinical pharmacologists can help reduce unsafe medication use in nursing homes. Researchers will review each resident's medications, give feedback to staff, and provide education. The study involves 219 residents aged 65+ in seven Swiss nursing homes, comparing outcomes before and after the intervention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that a structured medication review by clinical pharmacologists reduces unsafe prescribing and improves health outcomes for elderly nursing home residents.
What could go wrong
This is a small, non-randomized study with no control group, so results may not be generalizable. The intervention is complex and may be difficult to implement in other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INAPPROPRIATE PRESCRIBING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INAPPROPRIATE PRESCRIBING

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale

    Lugano, 6900, Switzerland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.